Optimal Rhythm Control Strategy in Patients With Atrial Fibrillation

다국어 초록 (Multilingual Abstract)

For almost 20 years, data regarding the effect of rhythm control therapy for atrial fibrillation (AF) on cardiovascular prognosis in comparison with rate control therapy has not been conclusive. The safety of rhythm control and anticoagulation therapy has generally improved. Recently, it was revealed that a rhythm-control strategy reduced the risk of adverse cardiovascular events than usual rate control in patients with recent AF (diagnosed within 1 year). Within 1 year after the AF diagnosis, early initiation of rhythm control led to more favorable cardiovascular outcomes than rate control. Early rhythm control reduced the risks of stroke and heart failure-related admission than rate control. Moreover, rhythm control was associated with lower dementia risk than rate control. Finally, early rhythm control treatment was also effective in patients with asymptomatic AF but less effective in older adults. Therefore, in patients with AF, rhythm control should be considered at earlier stages, regardless of symptom.

참고문헌 (Reference)

1 Camm AJ, "XANTUS : a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation" 37 : 1145-1153, 2016

2 Rolf S, "What can rhythm control therapy contribute to prognosis in atrial fibrillation?" 101 : 842-846, 2015

3 Rockwood K, "What are frailty instruments for?" 44 : 545-547, 2015

4 Kim D, "Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation : nationwide cohort study" 373 : n991-, 2021

5 Bunch TJ, "The impact of age on 5-year outcomes after atrial fibrillation catheter ablation" 27 : 141-146, 2016

6 Yang PS, "The effect of integrated care management on dementia in atrial fibrillation" 9 : 9-, 2020

7 이한철 ; 정보영 ; 김태훈 ; 백용수 ; 엄재선 ; 박희남 ; 이문형, "The Trends of Atrial Fibrillation-Related Hospital Visit and Cost, Treatment Pattern and Mortality in Korea: 10-Year Nationwide Sample Cohort Data" 대한심장학회 47 (47): 56-64, 2017

8 Willems S, "Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms : the EAST-AFNET 4 trial" 43 : 1219-1230, 2022

9 Kirchhof P, "Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation(Flec-SL) : a prospective, randomised, open-label, blinded endpoint assessment trial" 380 : 238-246, 2012

10 Srivatsa UN, "Risk predictors of stroke and mortality after ablation for atrial fibrillation : the California experience 2005-2009" 11 : 1898-1903, 2014

11 Kim D, "Risk of dementia in stroke-free patients diagnosed with atrial fibrillation : data from a population-based cohort" 40 : 2313-2323, 2019

12 정보영, "Risk Factor Management for Atrial Fibrillation" 대한심장학회 49 (49): 794-807, 2019

13 Tsadok MA, "Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation" 126 : 2680-2687, 2012

14 Roy D, "Rhythm control versus rate control for atrial fibrillation and heart failure" 358 : 2667-2677, 2008

15 Yang PS, "Reduction of mortality by catheter ablation in real-world atrial fibrillation patients with heart failure" 11 : 4694-, 2021

16 ShariffN, "Rate-control versus rhythm-control strategies and outcomes in septuagenarians with atrial fibrillation" 126 : 887-893, 2013

17 Gillinov AM, "Rate control versus rhythm control for atrial fibrillation after cardiac surgery" 374 : 1911-1921, 2016

18 Carlsson J, "Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation : the Strategies of Treatment of Atrial Fibrillation(STAF)study" 41 : 1690-1696, 2003

19 Cosedis Nielsen J, "Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation" 367 : 1587-1595, 2012

20 Khan MN, "Pulmonary-vein isolation for atrial fibrillation in patients with heart failure" 359 : 1778-1785, 2008

21 Shah RU, "Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation" 59 : 143-149, 2012

22 Daehoon Kim ; Pil-Sung Yang ; 정보영, "Prevention of Dementia in Patients with Atrial Fibrillation" 대한심장학회 51 (51): 308-319, 2021

23 Bunch TJ, "Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation" 22 : 839-845, 2011

24 Talajic M, "Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation" 55 : 1796-1802, 2010

25 Kim D, "Lower dementia risk with anticoagulation and ablation in patients with atrial fibrillation" 22 : 17-, 2021

26 Ganesan AN, "Long-term outcomes of catheter ablation of atrial fibrillation : a systematic review and meta-analysis" 2 : e004549-, 2013

27 Dinshaw L, "Long-term efficacy and safety of radiofrequency catheter ablation of atrial fibrillation in patients with cardiac implantable electronic devices and transvenous leads" 30 : 679-687, 2019

28 Kim D, "Less dementia after catheter ablation for atrial fibrillation : a nationwide cohort study" 41 : 4483-4493, 2020

29 Steinberg BA, "International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation : results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries" 194 : 132-140, 2017

30 Kim D, "Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006through 2015" 104 : 2010-2017, 2018

31 Kirchhof P, "Improving outcomes in patients with atrial fibrillation : rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial" 166 : 442-448, 2013

32 Sohns C, "Impact of left ventricular function and heart failure symptoms on outcomes post ablation of atrial fibrillation in heart failure : CASTLE-AF trial" 13 : e008461-, 2020

33 Chung MK, "Functional status in rate-versus rhythm-control strategies for atrial fibrillation : results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management(AFFIRM)Functional Status Substudy" 46 : 1891-1899, 2005

34 Clegg A, "Frailty in elderly people" 381 : 752-762, 2013

35 Villacampa-Fernández P, "Frailty and multimorbidity : two related yet different concepts" 95 : 31-35, 2017

36 Timmis A, "European Society of Cardiology : cardiovascular disease statistics 2019" 41 : 12-85, 2020

37 Kumagai K, "Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation" 41 : 2197-2204, 2003

38 Hohnloser SH, "Effect of dronedarone on cardiovascular events in atrial fibrillation" 360 : 668-678, 2009

39 Mark DB, "Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation : the CABANA randomized clinical trial" 321 : 1275-1285, 2019

40 Packer DL, "Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation : the CABANA randomized clinical trial" 321 : 1261-1274, 2019

41 Kirchhof P, "Early rhythm-control therapy in patients with atrial fibrillation" 383 : 1305-1316, 2020

42 Kirchhof P, "Early and comprehensive management of atrial fibrillation : executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference ‘research perspectives in AF’" 30 : 2969-2977, 2009

43 Torp-Pedersen C, "Dofetilide in patients with congestive heart failure and left ventricular dysfunction" 341 : 857-865, 1999

44 Wazni OM, "Cryoballoon ablation as initial therapy for atrial fibrillation" 384 : 316-324, 2021

45 Andrade JG, "Cryoablation or drug therapy for initial treatment of atrial fibrillation" 384 : 305-315, 2021

46 Kim D, "Comparative effectiveness of early rhythm control versus rate control for cardiovascular outcomes in patients with atrial fibrillation" 10 : e023055-, 2021

47 Gibbs H, "Clinical outcomes in asymptomatic and symptomatic atrial fibrillation presentations in GARFIELD-AF : implications for AF screening" 134 : 893-901, 2021

48 Marijon E, "Causes of death and influencing factors in patients with atrial fibrillation : a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study" 128 : 2192-2201, 2013

49 Prabhu S, "Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction : the CAMERA-MRI study" 70 : 1949-1961, 2017

50 Jaïs P, "Catheter ablation versus antiarrhythmic drugs for atrial fibrillation : the A4 study" 118 : 2498-2505, 2008

51 Yang PS, "Catheter ablation improves mortality and other outcomes in real-world patients with atrial fibrillation" 9 : e015740-, 2020

52 Marrouche NF, "Catheter ablation for atrial fibrillation with heart failure" 378 : 417-427, 2018

53 Willems S, "Cabins, castles, and constant hearts : rhythm control therapy in patients with atrial fibrillation" 40 : 3793-3799, 2019

54 Kim D, "Blood pressure control and dementia risk in midlife patients with atrial fibrillation" 75 : 1296-1304, 2020

55 Nattel S, "Atrial remodeling and atrial fibrillation : mechanisms and implications" 1 : 62-73, 2008

56 Jin MN, "Atrial fibrillation catheter ablation improves 1-year follow-up cognitive function, especially in patients with impaired cognitive function" 12 : e007197-, 2019

57 Kim D, "Association of rhythm control with incident dementia among patients with atrial fibrillation : a nationwide population-based cohort study" 51 : afab248-, 2022

58 Kim D, "Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation" 23 : 184-195, 2021

59 Kirchhof P, "Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation" 39 : 2942-2955, 2018

60 Adelstein EC, "Amiodarone is associated with adverse outcomes in patients with sustained ventricular arrhythmias upgraded to cardiac resynchronization therapy-defibrillators" 30 : 348-356, 2019

61 Kim D, "Age and outcomes of early rhythm control in patients with atrial fibrillation : nationwide cohort study" 8 : 619-632, 2022

62 Packer DL, "Ablation versus drug therapy for atrial fibrillation in heart failure : results from the CABANA trial" 143 : 1377-1390, 2021

63 Di Biase L, "Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device : results from the AATAC multicenter randomized trial" 133 : 1637-1644, 2016

64 Jones DG, "A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure" 61 : 1894-1903, 2013

65 Pappone C, "A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation : the APAF Study" 48 : 2340-2347, 2006

66 Hunter RJ, "A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure(the CAMTAF trial)" 7 : 31-38, 2014

67 Van Gelder IC, "A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation" 347 : 1834-1840, 2002

68 Wyse DG, "A comparison of rate control and rhythm control in patients with atrial fibrillation" 347 : 1825-1833, 2002

69 Schnabel RB, "50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study : a cohort study" 386 : 154-162, 2015

70 Hindricks G, "2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery(EACTS) : the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology(ESC)Developed with the special contribution of the European Heart Rhythm Association(EHRA)of the ESC" 42 : 373-498, 2021

71 January CT, "2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation : a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons" 140 : e125-51, 2019

72 January CT, "2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation : a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society" 74 : 104-132, 2019

73 정보영 ; Jung Myung Lee ; Ki Hong Lee ; Tae-Hoon Kim ; 최의근 ; Woo-Hyun Lim ; Ki-Woon Kang ; Jaemin Shim ; 임홍의 ; Junbeom Park ; So-Ryoung Lee ; Young Soo Lee ; Jin-Bae Kim ; KHRS Atrial Fibrillation Guideline Working Group, "2018 Korean Guideline of Atrial Fibrillation Management" 대한심장학회 48 (48): 1033-1080, 2018

74 Kim D, "10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population" 202 : 20-26, 2018